Najm Soofi, MD
Gastroenterology · Ypsilanti, MINPI 1902949761
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,358 of the $6,064 with a category attached, or 88.4%. Ferring Pharmaceuticals Inc. accounts for 93.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $5,709 and has fallen 97.7% since, to $129 in 2025.
Across 12 payments — averaging $505.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$6K
- Biosense Webster, Inc.$129
- Pfizer$100
- Janssen Scientific Affairs, LLC$90
- Johnson & Johnson$27
- Merck$18
- plus $14 from 1 others
Across 263 payments — averaging $10,065 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$2M
- Janssen Research & Development, LLC$265K
- Eli Lilly$147K
- Bristol Myers Squibb$119K
- Takeda Pharmaceuticals U.S.A., Inc.$37K
- E.r. Squibb & Sons, L.L.C.$31K
What the payments were for
- Consulting fees$5,35888%
- Travel & lodging$1512%
- Food & beverage$5239%
- Education$331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 5 | $5,686 |
| Biosense Webster, Inc. | 1 | $129 |
| Pfizer | 2 | $100 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Johnson & Johnson | 1 | $27 |
| Merck | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,064 in reported general payments places this provider in the 70th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 52 | $1,415,963 |
| Humira(Cf) PenAdalimumab | 36 | $375,072 |
| Skyrizi On-BodyRisankizumab-Rzaa | 12 | $245,525 |
| Mesalamine | 34 | $17,397 |
| Balsalazide Disodium | 24 | $9,897 |
| Ursodiol | 14 | $5,485 |
| Colestipol Hcl | 17 | $3,291 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 154 | $2,740 |
| Budesonide DrBudesonide | 22 | $1,639 |
| Budesonide EcBudesonide | 12 | $1,288 |
| Azathioprine | 17 | $1,200 |
| Omeprazole | 78 | $1,199 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 54 | $1,006 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 33 | $836 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 13 | $537 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $27 | $1,415,96352 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 497 gastroenterology providers in Michigan.
Other gastroenterology in Ypsilanti
- Michael FineYpsilanti$49K
- Bradley WarrenYpsilanti$31K
- Mohannad Abou SalehYpsilanti$29K
- Jeremy FaridaYpsilanti$19K
- Aws HasanYpsilanti$18K
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.